Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew L Freedman

Showing results (1-10 of 179) with videos related to

Pageof 18
Sort By:
Genes & Cancer|July 23, 2011
Chromosome 8q24-Associated Cancers and MYCChiara Grisanzio, Matthew L Freedman
Science Translational Medicine|April 26, 2013
Clinical uncertainty of prostate cancer genetic risk panelsMark Pomerantz, Matthew L Freedman
Cancer Journal (Sudbury, Mass.)|December 14, 2011
The genetics of cancer riskMark M Pomerantz, Matthew L Freedman
The Mount Sinai Journal of Medicine, New York|November 25, 2010
Genetics of prostate cancer riskMark M Pomerantz, Matthew L Freedman
Bioinformatics (Oxford, England)|December 25, 2009
Power to detect selective allelic amplification in genome-wide scans of tumor dataNinad Dewal, Matthew L Freedman, Thomas LaFramboise, et al.
BJU International|June 5, 2007
Genetic determinants of prostate cancer riskMark M Pomerantz, Matthew L Freedman, Philip W Kantoff
Plos Genetics|September 9, 2010
Allelic selection of amplicons in glioblastoma revealed by combining somatic and germline analysisThomas LaFramboise, Ninad Dewal, Katherine Wilkins, et al.
Genome Research|November 18, 2011
Calling amplified haplotypes in next generation tumor sequence dataNinad Dewal, Yang Hu, Matthew L Freedman, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 10, 2015
Inference of transcriptional regulation in cancersPeng Jiang, Matthew L Freedman, Jun S Liu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 9, 2026
Precision Oncology 2.0: Guiding Magic Bullets With Expression-Based Liquid BiopsyGunsagar S Gulati, Toni K Choueiri, Matthew L Freedman, et al.
Pageof 18

Showing results (1-10 of 179) with videos related to

Sort By:
Pageof 18
Genes & Cancer|July 23, 2011
Chromosome 8q24-Associated Cancers and MYCChiara Grisanzio, Matthew L Freedman
Science Translational Medicine|April 26, 2013
Clinical uncertainty of prostate cancer genetic risk panelsMark Pomerantz, Matthew L Freedman
Cancer Journal (Sudbury, Mass.)|December 14, 2011
The genetics of cancer riskMark M Pomerantz, Matthew L Freedman
The Mount Sinai Journal of Medicine, New York|November 25, 2010
Genetics of prostate cancer riskMark M Pomerantz, Matthew L Freedman
Bioinformatics (Oxford, England)|December 25, 2009
Power to detect selective allelic amplification in genome-wide scans of tumor dataNinad Dewal, Matthew L Freedman, Thomas LaFramboise, et al.
BJU International|June 5, 2007
Genetic determinants of prostate cancer riskMark M Pomerantz, Matthew L Freedman, Philip W Kantoff
Plos Genetics|September 9, 2010
Allelic selection of amplicons in glioblastoma revealed by combining somatic and germline analysisThomas LaFramboise, Ninad Dewal, Katherine Wilkins, et al.
Genome Research|November 18, 2011
Calling amplified haplotypes in next generation tumor sequence dataNinad Dewal, Yang Hu, Matthew L Freedman, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 10, 2015
Inference of transcriptional regulation in cancersPeng Jiang, Matthew L Freedman, Jun S Liu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 9, 2026
Precision Oncology 2.0: Guiding Magic Bullets With Expression-Based Liquid BiopsyGunsagar S Gulati, Toni K Choueiri, Matthew L Freedman, et al.
Pageof 18